Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1→3)-β-D-glucan

European Journal of Pharmacology

Volumn 334, Issue 2-3, 1997, Pages 255-263

  Sakurai, Teruaki ^a   Kaise, Toshikazu ^a   Yadomae, Toshiro ^a   Matsubara, Chiyo ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

D glucan; D glucan receptor; Alveolar macrophage; Interferon ; Nitric oxide (NO); Serum component

Indexed keywords

ALBUMIN; FIBRONECTIN; GAMMA INTERFERON; LYMPHOKINE; LYSOSOME ENZYME; NITRIC OXIDE; PLASMA PROTEIN; RECOMBINANT GAMMA INTERFERON; SCLEROTINIA SCLEROTIORUM EXTRACT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASCOMYCOTA; BETA-GLUCANS; BIOLOGICAL RESPONSE MODIFIERS; BRONCHOALVEOLAR LAVAGE FLUID; FIBRONECTINS; GLUCANS; LYMPHOKINES; LYSOSOMES; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; PROTEIN BINDING; SERUM ALBUMIN;

EID: 0030869548     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01191-6     Document Type: Article

References (29)

1. Adachi, Y., Ohno, N., Yadomae, T., 1993. Inhibitory effect of β-glucans on zymosan-mediated hydrogen peroxide production by murine peritoneal macrophages. Biol. Pharm. Bull. 16, 462-467.
2. Akagawa, K.S., Tokunaga, T., 1985. Lack of binding of bacterial lipopolysaccharide to mouse lung macrophages and restoration of binding by γ interferon. J. Exp. Med. 162, 1444-1459.
3. Badger, A.M., Cooperband, S.R., Merluzzi, V.J., 1974. The production of proliferation inhibitory factor (PIF) by mouse spleen cells in vitro. J. Immunol. 112, 1435-1443.
4. De Belder, A.N., Granath, K., 1973. Preparation and properties of fluorescein-labelled dextrans. Carbohydr. Res. 30, 375-378.
5. Corradin, S.B., Mauel, J., 1991. Phagocytosis of Leishmania enhances macrophage activation by IFN-γ and lipopolysaccharide. J. Immunol. 146, 279-285.
6. Fidler, I.J., Darnell, J.H., Budmen, M.B., 1976. Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A. Cancer Res. 36, 3608-3615.
7. Janusz, M.J., Austen, K.F., Czop, J.K., 1988. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte β-glucan receptors. Immunology 65, 181-185.
8. Jorens, P.G., van Overveld, F.J., Bull, H., Vermeire, P.A., Herman, A.G., 1993. Muramyldipeptide and granulocyte-macrophage colony stimulating factor enhance interferon-γ-induced nitric oxide production by rat alveolar macrophages. Agents Actions 38, 100-105.
9. Kadish, J.L., Choi, C.C., Czop, J.K., 1986. Phagocytosis of unopsonized zymosan particles by trypsin-sensitive and β-glucan inhibitable receptors on bone marrow-derived murine macrophages. Immunol. Res. 5, 129-138.
10. Meitner, S.W., Bowen, W.H., Haidaris, C.J., 1990. Oral and esophageal Candida albicans infection in hyposalivatory rats. Infect. Immun. 58, 2228-2236.
11. Mullins, J.T., 1990. Regulatory mechanisms of β-glucan synthases in bacteria, fungi and plants. Physiol. Plant. 78, 309-314.
12. Nickerson, C.L., Jakab, G.J., 1990. Pulmonary antibacterial defenses during mild and severe influenza virus infection. Infect. Immun. 58, 2809-2814.
13. Ohno, N., Yadomae, T., 1987. Two different conformations of the antitumor β-D-glucan produced by Sclerotinia sclerotiorum IFO 9395. Carbohydr. Res. 159, 293-302.
14. Ohno, N., Suzuki, I., Yadomae, T., 1986. Structure and antitumor activity of a β-1,3-glucan, isolated from the culture filtrate of Sclerotinia sclerotiorum IFO 9395. Chem. Pharm. Bull. 34, 1362-1365.
15. Poste, G., Fidler, I.J., 1980. The pathogenesis of cancer metastasis. Nature 283, 139-146.
16. Prior, C., Haslam, P.L., 1992. In vivo levels and in vitro production of interferon-γ in fibrosing interstitial lung diseases. Clin. Exp. Immunol. 88, 280-287.
17. Sakurai, T., Suzuki, I., Kinoshita, A., Oikawa, S., Masuda, A., Ohsawa, M., Yadomae, T., 1991. Effect of intraperitoneally administered β-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages. Chem. Pharm. Bull 39, 214-217.
18. Sakurai, T., Hashimoto, K., Suzuki, I., Ohno, N., Oikawa, S., Masuda, A., Yadomae, T., 1992. Enhancement of murine alveolar macrophage functions by orally administered β-glucan. Int. J. Immunopharmacol. 14, 821-830.
19. Sakurai, T., Ohno, N., Yadomae, T., 1994. Changes in immune mediators in mouse lung produced by administration of soluble (1 → 3)-β-D-glucan. Biol. Pharm. Bull. 17, 617-622.
20. Sakurai, T., Ohno, N., Suzuki, I., Yadomae, T., 1995. Effect of fungal (1 → 3)-β-D-glucan obtained from Sclerotinia aclerotiorum on alveolar macrophage activation. Immunopharmacology 30, 157-166.
21. Sone, S., Fidler, I.J., 1980. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages. J. Immunol., 2454-2460.
22. Suzuki, I., Hashimoto, K., Yadomae, T., 1988a. The effects of a highly blanched β-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice. J. Pharmacobio-Dyn. 11, 527-532.
23. Suzuki, I., Tanaka, H., Adachi, Y., Yadomae, T., 1988b. Rapid measurement of phagocytosis by macrophages. Chem. Pharm. Bull. 36, 4871-4875.
24. Suzuki, I., Sakurai, T., Hashimoto, K., Oikawa, S., Masuda, A., Ohsawa, M., Yadomae, T., 1991. Inhibition of experimental pulmonary metastasis of Lewis lung carcinoma by orally administered β-glucan in mice. Chem. Pharm. Bull. 39, 1606-1608.
25. Szabo, T., Kadish, J.L., Czop, J.K., 1995. Biochemical properties of the ligand-binding 20-kDa subunit of the β-glucan receptors on human mononuclear phagocytes. J. Biol. Chem. 270, 2115-2145.
26. Takeyama, T., Suzuki, I., Ohno, N., Oikawa, S., Sato, K., Ohsawa, M., Yadomae, T., 1988. Distribution of grifolan NMF-5N (I/B), a chemially modified antitumor β-glucan in mice. J. Pharmacobio-Dyn. 11, 381-385.
27. Watts, C.L., Bruce, M.L., 1992. Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia. J. Pediatr. 121, 597-607.
28. Watts, C.L., Fanaroff, A.A., Bruce, M.C., 1992. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia. J. Pediatr. 120, 614-620.
29. Zhou, X., Jordana, M., Gauldie, J., 1992. IL-1β and IL-6 gene expression in alveolar macrophages - Modulation by extracellular matrices. Am. J. Physiol. 262, L600-L605.